Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in SPRO — Spero Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,450
-$12,193 QoQ
Shares Held
2,014
-64.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 59 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. SPRO ranks #329 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in SPRO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,450 2,014
2025-06-30 $16,643 5,739
2024-06-30 $2,546 1,959
2023-12-31 $463 315
2023-09-30 $363 300
2022-09-30 $86 43
2022-03-31 $1,706,043 196,097
2021-12-31 $2,923,345 182,595
2021-09-30 $3,315,676 180,102
2021-06-30 $30,111 2,157
2021-03-31 $30,337 2,061
2020-12-31 $22,045 1,137
2020-09-30 $6,997 627
2020-06-30 $7,157 529
2020-03-31 $4,670 578